Author, year, country | Study design | Maternal characteristics | Offspring | Reason of exclusion | ||||
---|---|---|---|---|---|---|---|---|
Age (year) | Sample size | Assessment | Age (year) | Outcome | ||||
Unadjusted for offspring's anthropometry | Adjusted for offspring's anthropometry | |||||||
Bucci et al., 2016, Finland | Retrospective cohort | 22–34 (range) | 17 | Maternal groups based on BMI prior to delivery: ≥28.1 vs. ≤26.3 |
71.5 ± 0.9 (mean ± SD) |
Higher level of: Insulin glucose muscle insulin sensitivity* | — | BMI assessed only prior to delivery |
Eriksson et al., 2014, The Netherlands | Retrospective cohort | 22–34 (range) | 13,345 | Maternal groups based on BMI prior to delivery: ≥28 vs. ≤24 | 56–70 (range) | Higher OR for diagnosed diabetes mellitus Type 2* | ‐ | BMI assessed only prior to delivery |
Mi et al., 2000, China | Prospective cohort | 22–33 (range) | 627 | BMI as continuous variable | 43–46 (range) | — | Negative regression coefficient for glucose insulin* | BMI assessed only at 15th and 38th weeks of gestation |
Shaikh et al., 2015, Pakistan | Cross‐sectional | 25.23 ± 3.68 (mean ± SD) | 24 | Maternal groups based on BMI in the third trimester: <22 vs. >23 | Newborn | Higher level of insulin glucose* HOMA‐IR | — | BMI assessed between 28 and 40 weeks of gestation |
Veena et al., 2013, India | Prospective cohort | 23.5 ± 4.0 (mean ± SD) | 504 | BMI at 30th week of gestation as continuous variable | 9.5 | Positive sdr regression coefficient for insulin* glucose | Positive sdr regression coefficient for insulin HOMA‐IR negative regression coefficient for glucose | BMI assessed only at 30th week of gestation |
Abbreviations: BMI, body mass index; HOMA‐IR, Homeostatic Measurement Assessment for Insulin Resistance; IQR, interquartile range; SD, standard deviation; sdr, standardized.
* p < 0.05.